Skip to content

Effect of topical silver sulfadiazine-cerium nitrate in treatment of moderate to severe burn

Comparison of the efficacy of topical silver sulfadiazine-cerium nitrate with silver sulfadiazine cream in in treatment of moderate and severe burns

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190927044902N1
Enrollment
112
Registered
2020-01-05
Start date
2019-10-22
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns and corrosions. Burn of unspecified body region, unspecified degree

Interventions

Intervention 1: control group: daily application of topical formulation of silver sulfadiazine, and closed dressing. Intervention 2: Intervention group: daily application of topical treatment with si

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Second and third degree burns according to Laund & Browder criteria Minimum burn rate of patients is 10% and maximum of 50% Patients are being hospitalized in the first 24 hours of a hospital bed. informed consent to enter the study .

Exclusion criteria

Exclusion criteria: Inhalation burn Electrical and chemical burns Burns on face and hands and perineum A history of known allergies to sulfonamides History of Methemoglobinemia Pregnancy and lactation G6PD deficiency Oliguria and Anuria Functional liver disorders Lack of satisfaction with the patient to enter or continue intervention

Design outcomes

Primary

MeasureTime frame
90% Re-epithelialization as complete restoration. Timepoint: 7, 14, 21 and 28 days after onset of treatment with formulation. Method of measurement: The Re-epithelialization rate will also be recorded as very slow (5-6 weeks), slow (about 4 weeks), moderate (2-3 weeks), or fast (about 10 days).

Secondary

MeasureTime frame
The pain of the patient. Timepoint: once every three days. Method of measurement: The use of the visual pain criterion will be evaluated and will be graded from 0-10.;Duration of hospitalization. Timepoint: Every 5 days. Method of measurement: Based on the percentage of grafts taken on day 5.;Infection frequency. Timepoint: Every week. Method of measurement: Wound culture.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEmad Molaei

Mashhad University of Medical Sciences

Molaeie942@mums.ac.ir+98 51 3180 1588

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026